Home
PB Ratio of Ind-swift Laboratories Ltd
Ind-Swift Laboratories Ltd
NSE: INDSWFTLAB
PB Ratio
Key Highlights
- The latest PB Ratio of Ind-Swift Laboratories Ltd is 0.7.
- The PB ratio of the Ind-Swift Laboratories Ltd is below 1 which indicates that the stock is undervalued.
- The P/B Ratio of Ind-Swift Laboratories Ltd changed from 1.1 on March 2021 to 0.5 on March 2025 . This represents a CAGR of -14.59% over 5 years.
Historical P/B Ratio of Ind-Swift Laboratories Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Ind-Swift Laboratories Ltd
Company Fundamentals for Ind-Swift Laboratories Ltd
Market Cap
876 Cr
EPS
3.6
P/E Ratio (TTM)
29.6
P/B Ratio (TTM)
0.7
Day’s High
108.9
Day’s Low
103.0
DTE
0.0
ROE
2.3
52 Week High
124.45
52 Week Low
67.15
ROCE
1.2
Market Price of Ind-Swift Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 20 Jan 2026 | 107.43 |
| 19 Jan 2026 | 111.25 |
| 16 Jan 2026 | 110.81 |
| 14 Jan 2026 | 101.15 |
| 13 Jan 2026 | 102.24 |
| 12 Jan 2026 | 90.96 |
| 09 Jan 2026 | 90.7 |
| 08 Jan 2026 | 91.14 |
| 07 Jan 2026 | 94.41 |
| 06 Jan 2026 | 89.66 |
SWOT Analysis Of Ind-Swift Laboratories Ltd
BlinkX Score for Ind-Swift Laboratories Ltd
Asset Value vs Market Value of Ind-Swift Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Ind-Swift Laboratories Ltd | 0.67 | 876.75 |
| Sun Pharmaceutical Industries Ltd | 99.4 | 386773 |
| Divis Laboratories Ltd | 576.7 | 159540 |
| Torrent Pharmaceuticals Ltd | 249.6 | 134529 |
| Cipla Ltd | 409.2 | 111299 |
| Company | |
|---|---|
| Ind-Swift Laboratories Ltd | 0.67 |
| Sun Pharmaceutical Industries Ltd | 99.4 |
| Divis Laboratories Ltd | 576.7 |
| Torrent Pharmaceuticals Ltd | 249.6 |
| Cipla Ltd | 409.2 |
PB Ratio of Ind-Swift Laboratories Ltd Explained
₹876.75
Market cap
₹160
Book Value per Share
0.7X
PB Ratio
Historical Market Cap of Ind-Swift Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Ind-Swift Laboratories Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Ind-Swift Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Ind-Swift Laboratories Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Ind-Swift Laboratories Ltd News Hub
Ind-Swift Laboratories consolidated net profit declines 94.55% in the June 2024 quarter
Net profit of Ind-Swift Laboratories declined 94.55% to Rs 0.94 crore in the quarter ended June 2024
Read more
13 Aug 24
Ind-Swift Laboratories standalone net profit declines 63.70% in the June 2024 quarter
Net profit of Ind-Swift Laboratories declined 63.70% to Rs 6.19 crore in the quarter ended June 2024
Read more
13 Aug 24
Ind-Swift Laboratories to discuss results
Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 202
Read more
03 Aug 24
Ind-Swift Laboratories to hold AGM
Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will be held o
Read more
03 Sept 24
